Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinoma
针对头颈部鳞状细胞癌患者的马格罗利单抗联合疗法的II期研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106085
Colevas, A D; Chin, V; Park, J J; Adkins, D; Phan, M; Fang, B; Forget, F; Amorim, J; Misiukiewicz, K; Costa, D Alpuim; Rainey, N; Even, C; Wong, D J; Kerrigan, K; Zhang, Y; Dong, M; Rong, R; Caldwell, K; Leung, C; Dinis, J